6701 - 6710 of 7730 Results
Title
Year
- Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis2014RESTRICTEDTitle: Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosisJournal Name: European Journal of NeurologyPublisher: WileyVol: 22Issue #: 2Start Page: 328End Page: 333Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ene.12572Best OA location URL: https://europepmc.org/articles/pmc4289423?pdf=renderCitation Count: 41
-
RESTRICTEDTitle: Task-rest modulation of basal ganglia connectivity in mild to moderate Parkinson’s diseaseJournal Name: Brain Imaging and BehaviorPublisher: Springer Science and Business Media LLCVol: 9Issue #: 3Start Page: 619End Page: 638Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11682-014-9317-9Best OA location URL: https://europepmc.org/articles/pmc4385510?pdf=renderCitation Count: 30
-
RESTRICTEDTitle: Network Analysis Identifies SOD2 mRNA as a Potential Biomarker for Parkinson's DiseaseJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 9Issue #: 10Start Page: e109042End Page: e109042Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0109042Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0109042&type=printableCitation Count: 28
-
RESTRICTEDTitle: A GCase Chaperone Improves Motor Function in a Mouse Model of SynucleinopathyJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 11Issue #: 4Start Page: 840End Page: 856Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-014-0294-xBest OA location URL: https://europepmc.org/articles/pmc4391384?pdf=renderCitation Count: 90
- Abnormal MoCA and normal range MMSE scores in Parkinson disease without dementia: Cognitive and neurochemical correlates2014RESTRICTEDTitle: Abnormal MoCA and normal range MMSE scores in Parkinson disease without dementia: Cognitive and neurochemical correlatesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #: 10Start Page: 1076End Page: 1080Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.07.008Best OA location URL: https://europepmc.org/articles/pmc4180768?pdf=renderCitation Count: 62
- ESCRT-mediated Uptake and Degradation of Brain-targeted α-synuclein Single Chain Antibody Attenuates Neuronal Degeneration In Vivo2014RESTRICTEDTitle: ESCRT-mediated Uptake and Degradation of Brain-targeted α-synuclein Single Chain Antibody Attenuates Neuronal Degeneration In VivoJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 22Issue #: 10Start Page: 1753End Page: 1767Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1038/mt.2014.129Best OA location URL: http://www.cell.com/article/S1525001616307808/pdfCitation Count: 80
-
RESTRICTEDTitle: Highlights of the Stockholm Congress: A Clinician's PerspectiveJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 1Issue #: 4Start Page: 277End Page: 279Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12093Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12093Citation Count: 0
- Hypersynchrony despite pathologically reduced beta oscillations in patients with Parkinson's disease: a pharmaco-magnetoencephalography study2014RESTRICTEDTitle: Hypersynchrony despite pathologically reduced beta oscillations in patients with Parkinson's disease: a pharmaco-magnetoencephalography studyJournal Name: Journal of NeurophysiologyPublisher: American Physiological SocietyVol: 112Issue #: 7Start Page: 1739End Page: 1747Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1152/jn.00383.2014Best OA location URL: https://europepmc.org/articles/pmc4157173Citation Count: 71
- Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease2014RESTRICTEDTitle: Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 35Issue #: 10Start Page: 2329End Page: 2346Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.03.032Best OA location URL: https://europepmc.org/articles/pmc4892899?pdf=renderCitation Count: 61
-
RESTRICTEDTitle: Novel insights into the neurobiology underlying LRRK2-linked Parkinson's diseaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 85Issue #:Start Page: 45End Page: 56Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2014.05.020Citation Count: 21